Geode Capital Management, LLC Precipio, Inc. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.5 - $17.4 $259 - $9,013	-518 Reduced 0.2%	256,608 $142,000
Q4 2021 Feb 11, 2022	SELL	$1.58 - $2.77 $7,092 - $12,434	-4,489 Reduced 1.72%	257,126 $406,000
Q3 2021 Nov 12, 2021	BUY	$2.78 - $3.63 $176,282 - $230,181	63,411 Added 31.99%	261,615 $737,000
Q2 2021 Aug 13, 2021	BUY	$1.8 - $5.25 $112,501 - $328,130	62,501 Added 46.06%	198,204 $719,000
Q1 2021 May 12, 2021	BUY	$2.1 - $3.89 $104,447 - $193,476	49,737 Added 57.86%	135,703 $313,000
Q4 2020 Feb 12, 2021	BUY	$1.94 - $2.64 $24,758 - $33,691	12,762 Added 17.43%	85,966 $177,000
Q3 2020 Nov 13, 2020	BUY	$1.16 - $7.0 $49,841 - $300,769	42,967 Added 142.1%	73,204 $179,000
Q2 2019 Aug 14, 2019	BUY	$1.89 - $9.15 $57,147 - $276,668	30,237 New	30,237 $102,000

340

Ticker PRPO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 22,736,500
Market Cap $143M
Description
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.